"Designing Growth Strategies is in our DNA"

U.S. Ventricular Assist Devices Market Size, Share & COVID-19 Impact Analysis, By Product (Left Ventricular Assist Device, Right Ventricular Assist Device, and Bi-Ventricular Assist Device), By Type (Pulsatile Flow and Continuous Flow), By Application (Bridge to Transplant (BTT), Bridge to Candidacy (BTC), Destination Therapy (DT), and Bridge to Recovery (BTR)), and By End-user (Hospitals & ASCs and Specialty Clinics & Others), and Country Forecast, 2023-2030

Last Updated: July 08, 2024 | Format: PDF | Report ID: FBI107850

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The U.S. ventricular assist devices market size was worth USD 582.0 million in 2022 and is projected to grow at a CAGR of 10.5% during the forecast period. 


Heart failure is a condition in which the normal functioning of the heart is disrupted. The U.S. has observed a significant increase in the prevalence of heart failure. According to data published by the Centers for Disease Control and Prevention (CDC), around 6.2 million people in the U.S. suffered heart failure in 2020. Moreover, the geriatric population is generally more prone to such cardiovascular conditions.


Ventricular assist devices (VADs) are mechanical circulatory support (MCS) solutions that support the functionality of a failing heart. These devices are implanted into the patient’s body to circulate blood from the heart's chambers to the whole body. The increasing prevalence of cardiovascular diseases is fueling the adoption of these devices.


During COVID-19 pandemic in 2020, the market experienced a decline in its growth. The decline was due to the low demand for ventricular assist devices, as non-emergency surgeries were postponed for a short period of time in 2020 to control the spread of the virus.


LATEST TRENDS


Market Players are Emphasizing on New Product Launches to Reduce the Mortality Rates Due to Heart Disorders


The prevalence of cardiovascular devices such as coronary heart disease has been increasing significantly in the U.S.



  • As per data published by the Centers for Disease Control and Prevention (CDC), in 2021, around 375,476 people died in the U.S. due to coronary heart diseases.


Therefore, market players have increased their focus on new product launches to provide effective treatment and control mortality rates due to heart diseases.



  • In October 2022, ABIOMED received the U.S. FDA approval for Impella RP Flex to treat right heart failure, especially when the right ventricle is unable to pump blood to the lungs.


DRIVING FACTORS


Rising Product Adoption in Destination Therapy to Fuel the Market Growth


Heart transplantation is an option in patients suffering from late stage heart failure, when the medications do not show any improvement.



  • As per the United Network for Organ Sharing Data, as of 2021, an estimated 31,238 heart transplantations occurred in the past ten years.


However, the process is very complex and comes with several side effects such as coronary allograft vasculopathy (CAV), infection, bleeding, and others. Moreover, the waiting time for patients is very long and could even take years. Besides, it becomes difficult for the patient to survive for this long with a failing heart.


The shortage of organ donors and the complexity associated with heart transplantation has increased the demand for alternate treatments. The adoption of alternate treatment options, such as ventricular assist device implantation, has increased. The devices can be used in destination therapy. Therefore, the increasing adoption of these devices has been fueling the U.S. ventricular assist devices market growth.


RESTRAINING FACTORS


Request a Free sample to learn more about this report.


High Cost of The Devices to Limit their Adoption


The increasing prevalence of heart failure and shortage of heart donors have increased the demand for ventricular assist devices. However, the devices are quite costly as compared to other treatment methods.



  • For instance, in the U.S., the left ventricular assist devices (LVAD) implantation surgery costs around USD 175,000 - USD 200,000. This cost includes the device cost and the surgery cost.


Such high costs associated with VAD implantation limit its adoption, restraining the market growth to some extent.


In 2021, around 7.6 million people in the U.S. suffered heart failure, with around 0.8 million people suffering from heart attacks every year.


SEGMENTATION


By Product Analysis


Based on product, the market is segmented into left ventricular assist device, right ventricular assist device, and bi-ventricular assist device.


The left ventricular assist device segment held a significant market size in 2022. Left ventricular assist device increases blood flow to the body, improves the function of kidneys, liver, brain, and other organs, and improves the overall patient strength. Such benefits associated with these devices are fueling their adoption in the market.


By Type of Flow Analysis


Based on the type of flow, the market is bifurcated into pulsatile flow and continuous flow.


The continuous flow segment dominated the market in 2022. Continuous flow devices are less prone to thromboembolic events, making it a suitable choice among patients suffering from advanced heart failure. The advantages of continuous flow devices over other devices is propelling the segmental growth.



  • According to a 2022 study published in the National Center for Biotechnology Information, 58% improved survival rate was reported among patients with the use of HeartMate 3, a continuous flow VAD.


By Application Analysis


Based on application, the market is categorized into destination therapy (DT), bridge to candidacy (BTC), bridge to recovery (BTR), and bridge to transplant (BTT).


The bridge to transplant (BTT) segment is expected to grow at the fastest CAGR during the forecast period. The growth is attributed to the limited availability of heart donors and long waiting hours for heart transplantation.



  • According to a study published by the American Institute for American Research, in 2022, approximately 100,000 Americans waits for organ transplants and over 6,000 die while waiting. This shortage of organ donors is further leading to the increasing demand for other treatment options such as VAD till the patient receives a heart donor.


By End-user Analysis


Based on end-user, the market is segmented into hospitals & ASCs, and specialty clinics & others.


The hospitals & ASCs segment accounted for a significant U.S. ventricular assist devices market share. The increasing government and regulatory bodies' focus on the investment in hospital infrastructure through various government policies is driving the segment growth.



  • In November 2022, the Centers for Disease Control & Prevention awarded more than USD 3.0 billion to improve U.S. health workforce and infrastructure. Thus, increasing initiatives by the government and private organization for improving the healthcare infrastructure are contributing to the growth of the segment in the market.


KEY INDUSTRY PLAYERS


In terms of the competitive landscape, the market includes established and emerging companies. Abbott accounted for a significant market share in 2022. The company's strong presence in the market is attributed to its strong focus on strategic initiatives to expand its product offerings in the market.


Other players operating in the market include ABIOMED (Johnson & Johnson Services, Inc.), Berlin Heart, and Jarvik Heart, Inc. The U.S. ventricular assist devices market players have been focusing on strengthening its presence by getting regulatory approvals for the commercialization of its products.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS: 



  • December 2022 – Johnson & Johnson Services, Inc. acquired ABIOMED which will help the company widen its product reach.

  • November 2022 – Jarvik Heart, Inc., conducted a clinical trial for their ventricular assist device named Jarvik 2015 to strengthen their product portfolio

  • August 2022 – Abbott announced the results of the patients implanted with its HeartMate 3 left ventricular assist device. The patients showed better survival rate with the implantation of this device which will increase the company's brand presence.


REPORT COVERAGE


An Infographic Representation of U.S. Ventricular Assist Devices Market

To get information on various segments, share your queries with us



The market report provides a detailed analysis of the market. It includes key points such as an overview of the technological advancements, the prevalence of heart failure in the U.S., and others. Additionally, it includes adoption of these devices in the U.S., new product launches, key industry developments such as mergers, collaborations, and acquisitions, and the impact of COVID-19 on this market. Besides this, the report offers insights into the market trends and highlights key industry dynamics. In addition to the aforementioned factors, it encompasses several factors that have contributed to the growth of the market over recent years.


Report Scope & Segmentation



















































  ATTRIBUTE



  DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 10.5% from 2023 to 2030



Unit



Value (USD Million)



Segmentation



By Product



  • Left Ventricular Assist Device

  • Right Ventricular Assist Device

  • Bi-Ventricular Assist Device



By Type of Flow



  • Pulsatile Flow

  • Continuous Flow



By Application



  • Bridge to Transplant (BTT)

  • Bridge to Candidacy (BTC)

  • Destination Therapy (DT)

  • Bridge to Recovery (BTR)



By End-user



  • Hospitals & ASCs

  • Specialty Clinics & Others






Frequently Asked Questions

Fortune Business Insights says that the U.S. market was worth USD 582.0 million in 2022.

The market is expected to exhibit a CAGR of 10.5% during the forecast period (2023-2030).

By product, the left ventricular assist device segment holds a key share in the U.S. market.

Abbott and ABIOMED are the top players in the market.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • 2019-2030
  • 2022
  • 2019-2021
  • 0

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X